Skip to main content
SpringerLink
Log in

Use of Solid Corrugated Particles to Enhance Powder Aerosol Performance

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. To study the dispersion performance of non-porous corrugated particles, with a focus on the effect of particle surface morphology on aerosolization of bovine serum albumin (BSA) powders.

Methods. The solid-state characteristics of the spray-dried BSA powders, one consisting of smooth spherical particles and another corrugated particles, were characterized by laser diffraction, X-ray powder diffraction, scanning electron microscopy, confocal microscopy, thermogravimetric analysis, surface area analyzer, and buoyancy method. The powders were dispersed using the Rotahaler® and the Dinkihaler® coupled to a four-stage liquid impinger operating at 30 to 120 L/min. Fine particle fraction (FPF) was expressed as the wt. % of BSA particles of size ≤5 μm collected from the liquid impinger.

Results. Apart from the morphology and morphology-related properties (specific surface area, envelope density), the corrugated particles and spherical particles of BSA had very similar solid-state characteristics (particle size distribution, water content, true density, amorphous nature). Using the Dinkihaler®, the FPFs of the corrugated particles were 10-20 wt. % higher than those of the smooth particles. Similar FPF differences were found for the powders dispersed by the Rotahaler®, but the relative changes were larger. In addition, the differences were inversely proportional to the air flows (17.3% at 30 L/min, 25.2% at 60 L/min, 13.8% at 90, 8.5% at 120 L/min). Depending on the inhaler, capsule and device retention and impaction loss at the impinger throat were lower for the corrugated particles.

Conclusions. Enhanced aerosol performance of powders can be obtained by surface modification of the particles. The surface asperities of the corrugated particles could lower the true area of contact between the particles, and thus reduce the powder cohesiveness. A distinct advantage of using corrugated particles is that the inhaler choice and air flow become less critical for these particles.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. D. Ganderton and N. M. Kassem. Dry powder inhaler. In D. Ganderton, T. Jones (eds.), Advances in Pharmaceutical Sciences, Academic Press, London, 1992. pp. 165-191.

    Google Scholar 

  2. H.-K. Chan and I. Gonda. Respirable form of crystals of cromoglycic acid. J. Pharm. Sci. 78:176-180 (1989).

    Google Scholar 

  3. K. A. Fults, I. F. Miller, and A. J. Hickey. Effect of particle morphology on emitted dose of fatty acid-treated disodium cromoglycate powder aerosols. Pharm. Dev. Technol. 2:67-79 (1997).

    Google Scholar 

  4. Y.-F. Maa, H. R. Costantino, P.-A. Nguyen, and C. C. Hsu. The effect of operating and formulation variables on the morphology of spray-dried protein particles. Pharm. Dev. Technol. 2:213-223 (1997).

    Google Scholar 

  5. Y.-F. Maa, P.-A. Nguyen, T. Sweeney, S. J. Shire, and C. C. Hsu. Protein inhalation powders: Spray drying vs spray freeze drying. Pharm. Res. 16:249-254 (1999).

    Google Scholar 

  6. R. Vanbever, J. Mintzes, J. Wan, J. Nice, D. Chen, R. Batycky, R. Langer, and D. A. Edwards. Formulation and physical characterization of large porous particles for inhalation. Pharm. Res. 16:1735-1742 (1999).

    Google Scholar 

  7. P. Lucas, K. Anderson, U. J. Potter, and J. N. Staniforth. Enhancement of small particle size dry powder aerosol formulations using an ultra low density additive. Pharm. Res. 16:1643-1647 (1999).

    Google Scholar 

  8. T. Tarara, J. Weers, and L. Dellamary. Engineered powders for inhalation. In R. N. Dalby, P. R. Byron, S. J. Farr, J. Peart (eds), Respiratory Drug Delivery VII Vol. 2, Serentec Press, Raleigh, North Carolina. 2000, pp. 413-416.

    Google Scholar 

  9. A. Ben-Jebria, D. H. Chen, M. L. Eskew, R. Vanbever, R. Langer, and D. A. Edwards. Large porous particles for sustained protection from carbachol-induced bronchoconstriction in guinea pigs. Pharm. Res. 16:555-561 (1999).

    Google Scholar 

  10. D. A. Edwards, J. Hanes, G. Caponetti, J. Hrkach, A. Ben-Jebria, M. L. Eskew, J. Mintzes, D. Deaver, N. Lotan, and R. Langer. Large porous particles for pulmonary drug delivery. Science 276: 1868-1871 (1997).

    Google Scholar 

  11. N. Y. K. Chew and H.-K. Chan. Influence of particle size, air flow and inhaler device on the dispersion of mannitol powders as aerosols. Pharm. Res. 16:1098-1103 (1999).

    Google Scholar 

  12. N. Y. K. Chew, D. F. Bagster, and H.-K. Chan. Effect of particle size, air flow and inhaler device on the aerosolisation of disodium cromoglycate powders. Int. J. Pharm. 206:75-83 (2000).

    Google Scholar 

  13. H. K. Chan, A. Clark, I. Gonda, M. Mumenthaler, and C. Hsu. Spray dried powders and powder blends of recombinant human deoxyribonuclease (rhDNase) for aerosol delivery. Pharm. Res. 14:431-437 (1997).

    Google Scholar 

  14. I. Gonda. Phyisco-chemical principles in aerosol delivery, In D. J. A. Crommelin and K. K. Midha (eds.), Topics in Pharmaceutical Sciences 1991, Chapter 7, Medpharm Sci. Publ., Stuttgart, 1992, pp. 95-115.

    Google Scholar 

  15. A. H. De Boer, D. Gjaltema, and P. Hagedoorn. Inhalation characteristics and their effects on in vitro drug delivery from dry powder inhalers. Part 2: Effect of peak flow rate (PIFR) and inspiration time on the in vitro drug release from three different types of commercial dry powder inhalers. Int. J. Pharm. 138:45-56 (1996).

    Google Scholar 

  16. K. J. Smith, H.-K. Chan, and K. F. Brown. Influence of flow rate on aerosol particle size distributions from pressurized and breath-actuated inhalers. J. Aerosol. Med. 11:231-245 (1998).

    Google Scholar 

  17. A. L. Adjei and P. K. Gupta. Dry-powder inhalation aerosols. In A. L. Adjei A. L., P. K. Gupta (eds.), Inhalation Delivery of Therapeutic Peptides and Proteins. M. Dekker, New York. 1997. pp. 625-665.

    Google Scholar 

  18. J. Wang, A. Ben-Jebria, and D. A. Edwards. Inhalation of estradiol for sustained system delivery. J. Aerosol Med. 12:27-36 (1999).

    Google Scholar 

  19. D. L. French, D. A. Edwards, and R. W. Niven. The influence of formulation on emission, deaggregation and deposition of dry powders for inhalation. J. Aerosol Sci. 27:769-783 (1996).

    Google Scholar 

  20. C. J. R. Sheppard and D. M. Shotton. Confocal Laser Scanning Microscopy. BIOS Scientific Publishers Ltd., Oxford, United Kingdom. 1997.

    Google Scholar 

  21. J. D. Brain and J. D. Blanchad. Mechanisms of particle deposition and clearance. In F. Moren, M. B. Dolovich, M. T. New-house, S. P. Newman (eds.), Aerosols in Medicine, Principles, Diagnosis and Therapy, Elsevier Science Publishers, New York, 1993 pp. 117-156.

    Google Scholar 

  22. M. B. Ranade. Adhesion and removal of fine particles on surfaces. Aerosol. Sci. Tech. 7:161-176 (1987).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Pharmacy, A15, University of Sydney, NSW, 2006, Australia

    Nora Y. K. Chew & Hak-Kim Chan

Authors
  1. Nora Y. K. Chew
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hak-Kim Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chew, N.Y.K., Chan, HK. Use of Solid Corrugated Particles to Enhance Powder Aerosol Performance. Pharm Res 18, 1570–1577 (2001). https://doi.org/10.1023/A:1013082531394

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1013082531394

Search

Navigation